2024 ICD-10-CM Diagnosis Code G70.1

Toxic myoneural disorders

ICD-10-CM Code:
G70.1
ICD-10 Code for:
Toxic myoneural disorders
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the nervous system
    (G00–G99)
    • Diseases of myoneural junction and muscle
      (G70-G73)
      • Myasthenia gravis and other myoneural disorders
        (G70)

G70.1 is a billable diagnosis code used to specify a medical diagnosis of toxic myoneural disorders. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Cholinergic crisis
  • Disorder of neuromuscular junction caused by botulinum toxin
  • Neuromuscular junction disorder caused by organic phosphorus compound ingestion
  • Pelagic paralysis
  • Poisoning due to tick bite
  • Tick paralysis
  • Toxic neuromuscular junction disorder
  • Toxic neuromuscular junction disorder
  • Toxic neuromuscular junction disorder
  • Toxic neuromuscular junction disorder

Clinical Classification

Clinical CategoryCCSR Category CodeInpatient Default CCSROutpatient Default CCSR
Drug induced or toxic related conditionINJ030N - Not default inpatient assignment for principal diagnosis or first-listed diagnosis.N - Not default outpatient assignment for principal diagnosis or first-listed diagnosis.
MyopathiesNVS018Y - Yes, default inpatient assignment for principal diagnosis or first-listed diagnosis.Y - Yes, default outpatient assignment for principal diagnosis or first-listed diagnosis.

Clinical Information

  • Tick Paralysis

    paralysis caused by a neurotropic toxin secreted by the salivary glands of ticks.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert G70.1 to ICD-9-CM

  • ICD-9-CM Code: 358.2 - Toxic myoneural disorder

Patient Education


Neuromuscular Disorders

Neuromuscular disorders affect your neuromuscular system. They can cause problems with:

  • The nerves that control your muscles
  • Your muscles
  • Communication between your nerves and muscles

These disorders can cause your muscles to become weak and waste away. You may also have symptoms such as spasms, twitching, and pain.

Examples of neuromuscular disorders include:

  • Amyotrophic lateral sclerosis
  • Muscular dystrophy
  • Myasthenia gravis
  • Spinal muscular atrophy

There can be different causes for these diseases. Many of them are genetic.This means they are inherited (run in families) or are caused by a new mutation in your genes. Some neuromuscular disorders are autoimmune diseases. Sometimes the cause is unknown.

Many neuromuscular diseases have no cure. But treatments may improve symptoms, increase mobility, and lengthen life.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.